A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
A large national study of U.S. veterans presented at ACR Convergence reveals that PTSD increases the risk of RA, especially in never-smokers, suggesting distinct immune mechanisms may drive disease in different exposure subgroups.
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
Over 70% of rheumatoid arthritis patients who screen positive for anxiety, depression, or fibromyalgia report memory, sleep, or fatigue problems, highlighting the value of symptom checklists in noninflammatory disease assessment.
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
A targeted workflow intervention involving pharmacists and coordinated care increased recombinant zoster vaccine uptake from 10% to over 15% among RA patients under 50—surpassing institutional goals and highlighting scalable strategies to...
Clinicians who participated in continuing medical education were more likely to switch to a Janus kinase inhibitor to treat their patients with rheumatoid arthritis after lack of response to anti-TNFs.
Clinicians who participated in continuing medical education were more likely to switch to a Janus kinase inhibitor to treat their patients with rheumatoid arthritis after lack of response to anti-TNFs.
Key predictors of demyelinating disease development included a diagnosis of axial spondyloarthritis, presence of inflammatory bowel disease, and a history of smoking.
Key predictors of demyelinating disease development included a diagnosis of axial spondyloarthritis, presence of inflammatory bowel disease, and a history of smoking.
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
Researchers aimed to evaluate how achieving different levels of clinical response or disease activity in patients with nonradiographic (nr-) and radiographic (r-) axial spondyloarthritis.
Researchers aimed to evaluate how achieving different levels of clinical response or disease activity in patients with nonradiographic (nr-) and radiographic (r-) axial spondyloarthritis.
